Linezolid.
Bell
Susan Givens
SG
All Children's Hospital, St. Petersburg, Florida, USA.
D000081:Acetamides / Q000494:pharmacology / Q000627:therapeutic use*; D000740:Anemia / Q000139:chemically induced; D000890:Anti-Infective Agents / Q000494:pharmacology / Q000627:therapeutic use*; D016470:Bacteremia / Q000188:drug therapy* / Q000453:epidemiology / Q000382:microbiology; D002986:Clinical Trials as Topic; D004334:Drug Administration Schedule; D016903:Drug Monitoring; D024881:Drug Resistance, Bacterial; D004363:Drug Utilization; D006801:Humans; D007231:Infant, Newborn; D017053:Infection Control; D015931:Intensive Care, Neonatal / Q000379:methods*; D000069349:Linezolid; D017283:Neonatal Nursing; D023303:Oxazolidinones / Q000494:pharmacology / Q000627:therapeutic use*; D018579:Patient Selection; D011500:Protein Synthesis Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D012449:Safety; D013921:Thrombocytopenia / Q000139:chemically induced; D014481:United States; D014486:United States Food and Drug Administration
D000081:Acetamides; D000890:Anti-Infective Agents; D023303:Oxazolidinones; D011500:Protein Synthesis Inhibitors; D000069349:Linezolid